Wolff Parkinson White Syndrome Market Growth Analysis and Foresight to 2023


Posted September 12, 2017 by shivkumar

Wolff Parkinson White Syndrome Market Information: By Types, By Treatment, By End Users - Global Forecast Till 2023

 
Market Research Future adds new report of “Wolff Parkinson White Syndrome Market Research Report- Global Forecast till 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of key players profiled in the report are

• AngioDynamics
• Medtronic
• Boston Scientific Corporation
• St. Jude Medical, LLC
• Abbott
• GlaxoSmithKline LLC
• Teva Pharmaceutical Industries
• Sanofi S.A.
• Novartis International AG

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/4224

Market Segments:

The global Wolff Parkinson White syndrome market has been segmented on the basis of types, diagnosis, treatment and end users.

• Based on Types, the market has been segmented as type A and type B

• Based on Diagnosis, the market has been segmented as Electrocardiogram (ECG), Electrophysiological testing

• Based on Treatment, the market has been segmented as drugs, cardioversion, radiofrequency catheter ablation, surgery, artificial pacemaker

• Based on the End Users, the market has been segmented as hospitals & clinics, academic & research

Market Highlight:

Wolff-Parkinson-White (WPW) syndrome is a rare congenital heart disorder involving irregularities in the electrical transmission system of the heart. In WPW syndrome, an abnormal alternate electrical pathway exists resulting in arrhythmias (abnormal heartbeat rhythms) and tachycardia (faster than normal heartbeats). WPW is congenital but, symptoms may not become apparent until adolescent. Approximately 10 to 20 % of individuals with WPW syndrome have a congenital heart defect, such as Ebstein’s anomaly. The disorder’s estimated prevalence is -3 people per 1,000 people in the United States.

The symptoms associated with WPW syndrome are irregular heartbeats especially supraventricular tachycardia, palpitations, dyspnea, chest pain, fatigue, atrial flutter, ventricular fibrillation, atrial fibrillation, anxiety, dizziness etc. These symptoms may result in cardiac arrest and sudden death.

Browse Report Details @ https://www.marketresearchfuture.com/reports/wolff-parkinson-white-syndrome-market-4224

The exact cause of WPW syndrome is unknown however genetic mutations and abnormal genes are the most suspected causes. WPW syndrome is often present at birth (congenital), but may not be detected until adolescence or later. Peak incidence has been reported in individuals between 30 and 40 years old in otherwise healthy adults.

The market drivers for Wolff Parkinson White syndrome are increasing screening for genetic diseases, rising awareness and growing income of people etc. The market restraints can be poor cure rates, poor efficacy and effectiveness drugs etc.

The global Wolff Parkinson White syndrome market is expected to reach US$ 1.2 billion by 2023, and the market is projected to grow at a CAGR of ~ 3.3 % during the forecast period 2017-2023.

Intended Audience

• Global Wolff Parkinson White syndrome treatment manufacturers & suppliers
• Research and development (R&D) companies
• Hospitals and clinics
• Academic institutes and universities

Regional analysis:

The Americas which are dominated by the US account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new instruments and surgical techniques in the US drives the Wolff Parkinson White syndrome market. The good reimbursement scenario and the greater awareness in the developed regions drive the market.

Enquire about this Report @ https://www.marketresearchfuture.com/enquiry/4224

Europe is the second largest market in the world due to high income and healthcare penetration. The European region is dominated by Germany and France. The presence of large screening programs in the developed regions drives the market for Wolff Parkinson White syndrome.

Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Akash Anand, Market Research Future
Country India
Categories Business , Health , Medical
Tags wolff parkinson white syndrome industry , wolff parkinson white syndrome market
Last Updated September 12, 2017